ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Mol Pharm Org Process Res 2024, Vol 12(2): 215

Nano-medicine Revolutionizing Healthcare: A Closer Look at Nanoparticle Drug Delivery

Calatayud Musaed*
Department of Medicine Research, Mahidol University, Thailand
*Corresponding Author : Calatayud Musaed, Department of Medicine Research, Mahidol University, Thailand, Email: calatayud.musaed@gmail.com

Received Date: Mar 01, 2024 / Published Date: Mar 29, 2024

Abstract

Nano-medicine, an interdisciplinary field at the intersection of nanotechnology and medicine, holds immense promise for revolutionizing healthcare. Central to this promise is nanoparticle drug delivery, a sophisticated approach that leverages nano scale materials to enhance the targeting, efficacy, and safety of therapeutics. This abstract provides a concise overview of the principles, applications, and future prospects of nanoparticle drug delivery in medicine. Nanoparticle drug delivery systems offer several advantages over conventional drug delivery methods, including improved targeting of diseased tissues, reduced systemic toxicity, and enhanced therapeutic efficacy. These nanoparticles can be engineered to encapsulate a wide range of drugs, including small molecules, proteins, and nucleic acids, and can be tailored to release their cargo in a controlled manner over time. Furthermore, nanoparticles can exploit various targeting strategies, such as passive accumulation in diseased tissues or active targeting through surface ligands, to achieve precise localization and uptake. In oncology, nanoparticle-based drug delivery systems have shown particular promise for improving the treatment of cancer by overcoming barriers such as poor drug solubility, limited bioavailability, and multidrug resistance. Similarly, in infectious diseases, neurology, and cardiovascular disorders, nanoparticle drug delivery holds potential for enhancing therapeutic outcomes and reducing side effects.

Citation: Musaed C (2024) Nano-medicine Revolutionizing Healthcare: A Closer Look at Nanoparticle Drug Delivery. J Mol Pharm Org Process Res 12: 215.

Copyright: © 2024 Musaed C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top